> Details

Ransohoff, Julia D.; Ritter, Victor; Purington, Natasha; Andrade, Karen; Han, Summer; Liu, Mina; Liang, Su-Ying; John, Esther M.; Gomez, Scarlett L.; Telli, Melinda L.; Schapira, Lidia; Itakura, Haruka; Sledge, George W.; Bhatt, Ami S.; Kurian, Allison W.

Antimicrobial exposure is associated with decreased survival in triple-negative breast cancer

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: Antimicrobial exposure is associated with decreased survival in triple-negative breast cancer
  • Contributor: Ransohoff, Julia D.; Ritter, Victor; Purington, Natasha; Andrade, Karen; Han, Summer; Liu, Mina; Liang, Su-Ying; John, Esther M.; Gomez, Scarlett L.; Telli, Melinda L.; Schapira, Lidia; Itakura, Haruka; Sledge, George W.; Bhatt, Ami S.; Kurian, Allison W.
  • Published: Springer Science and Business Media LLC, 2023
  • Published in: Nature Communications, 14 (2023) 1
  • Language: English
  • DOI: 10.1038/s41467-023-37636-0
  • ISSN: 2041-1723
  • Origination:
  • Footnote:
  • Description: AbstractAntimicrobial exposure during curative-intent treatment of triple-negative breast cancer (TNBC) may lead to gut microbiome dysbiosis, decreased circulating and tumor-infiltrating lymphocytes, and inferior outcomes. Here, we investigate the association of antimicrobial exposure and peripheral lymphocyte count during TNBC treatment with survival, using integrated electronic medical record and California Cancer Registry data in the Oncoshare database. Of 772 women with stage I-III TNBC treated with and without standard cytotoxic chemotherapy – prior to the immune checkpoint inhibitor era – most (654, 85%) used antimicrobials. Applying multivariate analyses, we show that each additional total or unique monthly antimicrobial prescription is associated with inferior overall and breast cancer-specific survival. This antimicrobial-mortality association is independent of changes in neutrophil count, is unrelated to disease severity, and is sustained through year three following diagnosis, suggesting antimicrobial exposure negatively impacts TNBC survival. These results may inform mechanistic studies and antimicrobial prescribing decisions in TNBC and other hormone receptor-independent cancers.
  • Access State: Open Access